Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Internal Medicine (Tokyo, Japan)
|
April 5, 2016
Six Cases of Pulmonary Mycobacterium shinjukuense Infection at a Single Hospital
Keita Takeda, Nobuharu Ohshima, Hideaki Nagai, et al.
Journal of Fungi (Basel, Switzerland)
|
April 25, 2025
Serum Type 2 Cytokine Levels Are Elevated in a Chronic Pulmonary Aspergillosis Subgroup with High Serum Total Immunoglobulin E Level
Shizuka Watanabe, Junko Suzuki, Maho Suzukawa, et al.
American Journal of Medical Genetics. Part A
|
February 26, 2015
A family of distal arthrogryposis type 5 due to a novel PIEZO2 mutation
Mariko Okubo, Atsushi Fujita, Yoshiaki Saito, et al.
JAMA Oncology
|
May 15, 2020
Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter Phase 2 Trial
Shingo Miyamoto, Koichi Azuma, Hidenobu Ishii, et al.
Kekkaku : [Tuberculosis]
|
September 20, 2011
[A case of tuberculous pleurisy developing contralateral effusion during anti-tuberculosis chemotherapy]
Takashi Ishii, Yoshinori Matsui, Naohiro Nagayama, et al.
Kekkaku : [Tuberculosis]
|
March 22, 2013
Doctor's delay in endobronchial tuberculosis
Atsuhisa Tamura, Naoko Higaki, Kei Kusaka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
February 4, 2021
Multi-Institutional Prospective Cohort Study of Patients With Pulmonary Hypertension Associated With Respiratory Diseases
Nobuhiro Tanabe, Hiraku Kumamaru, Yuichi Tamura, et al.
Therapeutic Advances in Medical Oncology
|
August 4, 2022
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study)
Shigeru Tanzawa, Tomonori Makiguchi, Sadatomo Tasaka, et al.
Therapeutic Advances in Medical Oncology
|
December 26, 2022
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis
Hisashi Tanaka, Shigeru Tanzawa, Toshihiro Misumi, et al.
Therapeutic Advances in Medical Oncology
|
March 15, 2021
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study)
Shigeru Tanzawa, Sunao Ushijima, Kazuhiko Shibata, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Internal Medicine (Tokyo, Japan)
|
April 5, 2016
Six Cases of Pulmonary Mycobacterium shinjukuense Infection at a Single Hospital
Keita Takeda, Nobuharu Ohshima, Hideaki Nagai, et al.
Journal of Fungi (Basel, Switzerland)
|
April 25, 2025
Serum Type 2 Cytokine Levels Are Elevated in a Chronic Pulmonary Aspergillosis Subgroup with High Serum Total Immunoglobulin E Level
Shizuka Watanabe, Junko Suzuki, Maho Suzukawa, et al.
American Journal of Medical Genetics. Part A
|
February 26, 2015
A family of distal arthrogryposis type 5 due to a novel PIEZO2 mutation
Mariko Okubo, Atsushi Fujita, Yoshiaki Saito, et al.
JAMA Oncology
|
May 15, 2020
Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter Phase 2 Trial
Shingo Miyamoto, Koichi Azuma, Hidenobu Ishii, et al.
Kekkaku : [Tuberculosis]
|
September 20, 2011
[A case of tuberculous pleurisy developing contralateral effusion during anti-tuberculosis chemotherapy]
Takashi Ishii, Yoshinori Matsui, Naohiro Nagayama, et al.
Kekkaku : [Tuberculosis]
|
March 22, 2013
Doctor's delay in endobronchial tuberculosis
Atsuhisa Tamura, Naoko Higaki, Kei Kusaka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
February 4, 2021
Multi-Institutional Prospective Cohort Study of Patients With Pulmonary Hypertension Associated With Respiratory Diseases
Nobuhiro Tanabe, Hiraku Kumamaru, Yuichi Tamura, et al.
Therapeutic Advances in Medical Oncology
|
August 4, 2022
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study)
Shigeru Tanzawa, Tomonori Makiguchi, Sadatomo Tasaka, et al.
Therapeutic Advances in Medical Oncology
|
December 26, 2022
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis
Hisashi Tanaka, Shigeru Tanzawa, Toshihiro Misumi, et al.
Therapeutic Advances in Medical Oncology
|
March 15, 2021
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study)
Shigeru Tanzawa, Sunao Ushijima, Kazuhiko Shibata, et al.
Page
of 2